Given a patient with a serum bicarbonate of 12 mmol/L (reference 21‑31) and macrocytic anemia (hemoglobin 10.8 g/dL, hematocrit 36.8 %, mean corpuscular volume 102 fL) along with the accompanying complete blood count results, what further laboratory tests should be ordered and what immediate management recommendations should be made?

Immediate Management: Confirm True Metabolic Acidosis and Initiate Vitamin B12 Workup

Before treating the low bicarbonate, you must first obtain an arterial blood gas (ABG) to rule out pseudohypobicarbonatemia, as the severely low CO2 of 12 mmol/L may represent laboratory interference rather than true metabolic acidosis. Simultaneously, order vitamin B12, folate, methylmalonic acid (MMA), homocysteine, and a reticulocyte count to evaluate the macrocytic anemia.

Critical First Step: Verify the Bicarbonate

The serum bicarbonate of 12 mmol/L is critically low and would typically indicate severe metabolic acidosis requiring urgent intervention. However, pseudohypobicarbonatemia must be excluded before initiating bicarbonate therapy 1, 2. This phenomenon occurs when:

• Paraproteinemia interferes with enzymatic assays 1
• Severe hypertriglyceridemia causes laboratory interference 2
• The discrepancy is revealed when ABG shows normal pH and bicarbonate despite low serum values

Order an ABG immediately. If the ABG shows normal pH (7.35-7.45) and normal bicarbonate (22-26 mmol/L), this confirms pseudohypobicarbonatemia and no acid-base treatment is needed. If the ABG confirms true metabolic acidosis, then calculate the anion gap and pursue causes of high anion gap metabolic acidosis (uremia, ketoacidosis, lactic acidosis, toxins).

Macrocytic Anemia Evaluation

Your patient has clear macrocytic anemia:

• Hemoglobin: 10.8 g/dL (low)
• MCV: 102 fL (elevated, reference 80-98)
• MCHC: 29.3 g/dL (low, suggesting hypochromia)

Immediate Laboratory Orders

Order the following tests now:

1. Vitamin B12 level - Most likely cause given MCV 102 fL 3, 4
2. Folate level - Essential to differentiate deficiency types 5, 6
3. Methylmalonic acid (MMA) - Elevated in B12 deficiency; helps confirm diagnosis when B12 is borderline 7
4. Homocysteine - Elevated in both B12 and folate deficiency; provides functional assessment 7
5. Reticulocyte count - Assesses bone marrow response 5
6. Peripheral blood smear review - Look for macro-ovalocytes, hypersegmented neutrophils, teardrop cells 5, 3
7. Thyroid function tests (TSH, free T4) - Hypothyroidism causes macrocytosis 6
8. Liver function tests - Already ordered in CMP; review for liver disease 3, 6

Interpretation Framework

MCV 102 fL suggests vitamin B12 deficiency is most likely 3, 4. Studies show:

• MCV >110 fL strongly predicts megaloblastic anemia 4
• MCV 100-110 fL (like your patient) can be B12 deficiency, but also drugs, alcohol, liver disease, or hypothyroidism 3, 6
• B12 levels ≤257 ng/L (using Roche assay) indicate severe deficiency 7
• B12 levels 258-341 ng/L suggest early depletion and should be confirmed with elevated homocysteine 7

The low MCHC (29.3 g/dL) is unusual for pure megaloblastic anemia and raises concern for dimorphic anemia (combined B12/folate deficiency with iron deficiency) 8. Review the CMP for iron studies if included.

Additional Considerations

Check medication history carefully:

• Metformin, proton pump inhibitors, H2 blockers impair B12 absorption
• Chemotherapy agents, anticonvulsants, methotrexate cause macrocytosis 3, 6

Assess for alcohol use - Most common cause of macrocytosis in hospitalized patients 3

The mild lymphopenia (16%, absolute 1.5) and slightly elevated monocytes/eosinophils are nonspecific but document them for trend monitoring.

Management Algorithm

If ABG Confirms True Metabolic Acidosis (pH <7.35, HCO3 <22):

1. Calculate anion gap from CMP
2. If high anion gap: evaluate for uremia (check creatinine from CMP), ketoacidosis, lactic acidosis, toxic ingestions
3. Consider bicarbonate therapy only if pH <7.1 or symptomatic
4. Address underlying cause

If ABG Shows Normal Acid-Base Status (Pseudohypobicarbonatemia):

1. Document the discrepancy
2. Check for paraproteinemia (SPEP/UPEP) or severe hypertriglyceridemia
3. No bicarbonate therapy needed
4. Use ABG for future bicarbonate monitoring in this patient

For Macrocytic Anemia - Once B12/Folate Results Return:

If B12 <200 pg/mL or MMA/homocysteine elevated:

• Start vitamin B12 1000 mcg IM daily × 7 days, then weekly × 4 weeks, then monthly 9
• Expect reticulocyte response in 3-7 days
• Hemoglobin should improve by 2-3 g/dL within 6 weeks 9
• Do NOT wait for results if patient has neurological symptoms (though none clearly documented here)

If folate deficient:

• Folic acid 1-5 mg daily orally
• Always supplement B12 first or simultaneously to avoid precipitating subacute combined degeneration

If B12/folate normal:

• Pursue thyroid dysfunction, liver disease, myelodysplastic syndrome
• Consider hematology referral if no clear cause or if patient >55 years with refractory macrocytosis (MDS risk) 4

Common Pitfalls to Avoid

1. Do not treat the low bicarbonate without ABG confirmation - you may be treating a laboratory artifact 1, 2
2. Do not give folate alone without checking B12 - can worsen neurological complications of B12 deficiency
3. Do not assume macrocytosis = megaloblastic anemia - drugs and alcohol are more common causes 3
4. Do not overlook dimorphic anemia - the low MCHC suggests possible concurrent iron deficiency 8
5. In patients >55 years with unexplained macrocytosis, consider myelodysplastic syndrome 4